NDC 42494-457 – Entecavir
Entecavir Anhydrous .5 mg/1 · Tablet · Oral
Product NDC42494-457
Product details
- Brand name
- Entecavir
- Generic name
- Entecavir Anhydrous
- Labeler
- Cameron Pharmaceuticals
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA216857
- Marketed since
- May 15, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Entecavir Anhydrous .5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42494-457-30 | 30 TABLET in 1 BOTTLE (42494-457-30) | May 15, 2025 |
Other Entecavir products
- 60687-216 Entecavir .5 mg/1 · Tablet · American Health Packaging
- 65862-841 Entecavir .5 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-842 Entecavir 1 mg/1 · Tablet · Aurobindo Pharma Limited
- 31722-833 Entecavir Anhydrous .5 mg/1 · Tablet · Camber Pharmaceuticals, Inc.
- 31722-834 Entecavir Anhydrous 1 mg/1 · Tablet · Camber Pharmaceuticals, Inc.
- 42494-458 Entecavir Anhydrous 1 mg/1 · Tablet · Cameron Pharmaceuticals
- 61442-311 Entecavir .5 mg/1 · Tablet · Carlsbad Technology, Inc.
- 42806-658 Entecavir .5 mg/1 · Tablet · EPIC PHARMA, LLC
- 42806-659 Entecavir 1 mg/1 · Tablet · EPIC PHARMA, LLC
- 51407-589 Entecavir .5 mg/1 · Tablet · Golden State Medical Supply, Inc.
- 65162-449 Entecavir 1 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals LLC
- 65162-446 Entecavir .5 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals LLC